BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
-10.66%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$551M
AUM Growth
–
Cap. Flow
+$551M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
31.05%
Holding
130
New
130
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Gilead Sciences
GILD
|
$21.4M |
| 2 |
CELG
Celgene Corp
CELG
|
$21.1M |
| 3 |
Medtronic
MDT
|
$20.7M |
| 4 |
Biogen
BIIB
|
$19.9M |
| 5 |
Abbott
ABT
|
$16M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 93% |
| 2 | Financials | 1.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Incyte
INCY
$16.5B
| $6.6M | 1.2% | +91,000 | New | +$6.6M |
|
27
Cigna
CI
$80.3B
| $6.59M | 1.2% | +48,000 | New | +$6.59M |
|
28
Centene
CNC
$14.3B
| $6.52M | 1.18% | +105,880 | New | +$6.52M |
|
29
Edwards Lifesciences
EW
$47.8B
| $6.44M | 1.17% | +73,000 | New | +$6.44M |
|
30
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $6.09M | 1.11% | +287,000 | New | +$6.09M |
|
|
SHPG
31
DELISTED
Shire pic
SHPG
| $5.82M | 1.06% | +33,880 | New | +$5.82M |
|
32
Ionis Pharmaceuticals
IONS
$6.8B
| $5.59M | 1.01% | +138,000 | New | +$5.59M |
|
33
Humana
HUM
$36.5B
| $5.49M | 1% | +30,000 | New | +$5.49M |
|
34
Johnson & Johnson
JNJ
$427B
| $5.41M | 0.98% | +50,000 | New | +$5.41M |
|
|
MNK
35
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $5.39M | 0.98% | +88,000 | New | +$5.39M |
|
36
BioMarin Pharmaceuticals
BMRN
$11.2B
| $5.36M | 0.97% | +65,000 | New | +$5.36M |
|
37
Baxter International
BAX
$12.7B
| $5.34M | 0.97% | +130,000 | New | +$5.34M |
|
38
Vertex Pharmaceuticals
VRTX
$100B
| $5.25M | 0.95% | +66,000 | New | +$5.25M |
|
|
HZNP
39
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $5.14M | 0.93% | +310,000 | New | +$5.14M |
|
|
BCR
40
DELISTED
CR Bard Inc.
BCR
| $5.07M | 0.92% | +25,000 | New | +$5.07M |
|
|
AET
41
DELISTED
Aetna Inc
AET
| $5.06M | 0.92% | +45,000 | New | +$5.06M |
|
|
ENDP
42
DELISTED
Endo International plc
ENDP
| $4.81M | 0.87% | +171,000 | New | +$4.81M |
|
43
HCA Healthcare
HCA
$94.5B
| $4.68M | 0.85% | +60,000 | New | +$4.68M |
|
|
INSY
44
DELISTED
Insys Therapeutics, Inc.
INSY
| $4.49M | 0.82% | +281,000 | New | +$4.49M |
|
45
Perrigo
PRGO
$3.27B
| $4.17M | 0.76% | +32,600 | New | +$4.17M |
|
46
Elevance Health
ELV
$71.8B
| $4.17M | 0.76% | +30,000 | New | +$4.17M |
|
|
ESRX
47
DELISTED
Express Scripts Holding Company
ESRX
| $4.03M | 0.73% | +58,600 | New | +$4.03M |
|
|
XENT
48
DELISTED
Intersect ENT, Inc
XENT
| $3.98M | 0.72% | +209,246 | New | +$3.98M |
|
49
Bristol-Myers Squibb
BMY
$96B
| $3.83M | 0.7% | +60,000 | New | +$3.83M |
|
50
Eagle Bancorp
EGBN
$590M
| $3.78M | 0.69% | +93,400 | New | +$3.78M |
|